1Asmar R,Benetos A,Topouchian J,et al.Assessment of arterial distensibility by automatic pulse wave velocity measurement.Validation and clinical application studies.Hypertension,1995,26:485-490.
2Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP)expert panel on detection,evaluation,and treatment of the high blood cholesterol in adults (Adult Treatment Panel Ⅲ).JAMA,2001,285:2486-2497.
3Alberti KG,Zimmet PZ.Definition,diagnosis,and classification of diabetes mellitus and its complications.Part 1,diagnosis and classification of diabetes mellitus,provisional report of a WHO consultation.Diabet Med,1998,15:539-553.
4Alberti KG,Zimmet PZ,Shaw J.The metabolic syndromea new worldwide definition.Lancet,2005,366:1059-1062.
6Athyros VG,Ganotakis ES,Elisaf MS,et al.Prevalence of vascular disease in metabolic syndrome using three proposed definitions.Int J Cardiol,2007,117:204-210.
7Chen HY,Kao TW,Huang JW,et al.Correlation of metabolic syndrome with residual renal function,solute transport rate and peritoneal solute clearance in chronic peritoneal dialysis patients.Blood Purif,2008,26:138-144.
1Reinhold M, Deppisch W, Hermann G. Complement components as uremic toxins and their potential role as mediators of microinflammation. Kidney Int, 2001,59:271-279.
2Ikeda U, Ileda M, Seiono Y, et al. Interleukin -6 gene transcripts are expressed in atherrosclerotic lesion of the genetically hyperlipidemic rabbits. Atherosclerosis, 1992,92: 213-218.
3Antonio S, Elena M. Cardiac effects of chronic inflammation in dialysis patients. Nephrol Dial Transplant. 2002,17: 10-15.
4Kim K J, Yang WS, Kim SB, et al. Malnutrition, cardiac disease,and mortality: an integrated point of view. Am J Kindey Dis,1998, 32: 834-841.
5Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis,1998; 32: s112-s119.
6Ridker PM, Buring JE, Shin J. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparentl healthy women. Circulation, 1998,98:731-733.
7George A. The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol,2001,12: 1549-1557.
8Vigushin DM, Pepys MB. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest, 1993,91: 1351-1357.
4Carnethon MR, Loria CM, Hill JO. Risk factors for the metabolic syndrome: the Coronary Artery Risk Development in Young Adults (CARDIA) study, 1985-2001. Diabetes Care, 2004, 27: 2707-2715.
5Davies SJ, Phillips L, Naish PF, et al. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol, 2001, 12: 1046-1051.
6Ainsworth BE, Haskell WL, Whitt MC, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exere, 2000, 32: S498-S504.
7Institute of Medicine/Food and Nutrition Board. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids. Washington DC: National Academy Press, 2002: 697-736.
8Jiang N, Qian J, Lin A, et al. Initiation of glucose-based peritoneal dialysis is associated with increased prevalence of metabolic syndrome in non-diabetic patients with end-stage renal disease. Blood Purif, 2008, 26: 423-428.
9Little J, Phillips L, Russell L. Longitudinal lipid profiles on CAPD: their relationship to weight gain, comorbidity, and dialysis factors. J Am Soc Nephrol, 1998, 9: 1931-1939.
10Chen HY, Kao TW, Huang JW, et al. Correlation of metabolic syndrome and parameters of peritoueal dialysis. Blood Purif, 2008, 26: 138-144.
